The Accutane Lawyers of Williams Kherkher Discuss New IBD Treatment Study
(firmenpresse) - HOUSTON, TX -- (Marketwire) -- 11/08/11 -- A at the University of North Carolina at Chapel Hill may help individuals suffering from inflammatory bowel disease improve their treatment to address unique problems. The study followed patients that utilized a PillCam style endoscopy which allows doctors a better view of the intestinal tract than other types of endoscopy.
After information was gathered about the condition of the patients' intestines, over 60% of them changed their inflammatory bowel disease treatment. By getting more information about the condition of certain sections of intestines, medical professionals are better able to target treatment for their patients.
Managing medication carefully is the best way to treat , , and . Some research has linked this type of health complication with Accutane use. The of Williams Kherkher are prepared to work with individuals that have suffered from these intestinal complications possibly caused by Accutane use.
About Williams Kherkher
Williams Kherkher is a mass-tort law firm based in Houston, Texas, offering legal assistance to clients nationwide. The firm handles a variety of cases, including those involving personal injury law, mesothelioma, and defective pharmaceuticals such as Accutane. For more information about the Accutane lawsuits and your rights as a victim, contact the of Williams Kherkher at 800-641-9810 today or visit the website at .
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.11.2011 - 15:04 Uhr
Sprache: Deutsch
News-ID 1054876
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
HOUSTON, TX
Phone:
Kategorie:
Health & Nutrition
Anmerkungen:
Diese Pressemitteilung wurde bisher 177 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"The Accutane Lawyers of Williams Kherkher Discuss New IBD Treatment Study
"
steht unter der journalistisch-redaktionellen Verantwortung von
Williams Kherkher (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
